Literature DB >> 15548585

GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development.

Erin B Harmon1, Asa A Apelqvist, Nora G Smart, Xueying Gu, Douglas H Osborne, Seung K Kim.   

Abstract

Identification of endogenous signals that regulate expansion and maturation of organ-specific progenitor cells is a major goal in studies of organ development. Here we provide evidence that growth differentiation factor 11 (GDF11), a member of the TGF-beta ligand family, governs the number and maturation of islet progenitor cells in mouse pancreas development. Gdf11 is expressed in embryonic pancreatic epithelium during formation of islet progenitor cells that express neurogenin 3. Mice deficient for Gdf11 harbor increased numbers of NGN3+ cells, revealing that GDF11 negatively regulates production of islet progenitor cells. Despite a marked expansion of these NGN3+ islet progenitors, mice lacking Gdf11 have reduced beta-cell numbers and evidence of arrested beta-cell development, indicating that GDF11 is also required for beta-cell maturation. Similar precursor and islet cell phenotypes are observed in mice deficient for SMAD2, an intracellular signaling factor activated by TGF-beta signals. Our data suggest that Gdf11 and Smad2 regulate islet cell differentiation in parallel to the Notch pathway, which previously has been shown to control development of NGN3+ cells. Thus, our studies reveal mechanisms by which GDF11 regulates the production and maturation of islet progenitor cells in pancreas development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548585     DOI: 10.1242/dev.01535

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  69 in total

1.  Growth/differentiation factor-11: an evolutionary conserved growth factor in vertebrates.

Authors:  Bruria Funkenstein; Elena Olekh
Journal:  Dev Genes Evol       Date:  2010-08-07       Impact factor: 0.900

Review 2.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

4.  Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.

Authors:  Tommaso Poggioli; Ana Vujic; Peiguo Yang; Claudio Macias-Trevino; Aysu Uygur; Francesco S Loffredo; James R Pancoast; Miook Cho; Jill Goldstein; Rachel M Tandias; Emilia Gonzalez; Ryan G Walker; Thomas B Thompson; Amy J Wagers; Yick W Fong; Richard T Lee
Journal:  Circ Res       Date:  2015-10-21       Impact factor: 17.367

5.  Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors.

Authors:  Melissa L Brown; Nathan Ungerleider; Lara Bonomi; Danielle Andrzejewski; Amy Burnside; Alan Schneyer
Journal:  Islets       Date:  2014       Impact factor: 2.694

6.  Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.

Authors:  Nabeel Bardeesy; Kuang-Hung Cheng; Justin H Berger; Gerald C Chu; Jessica Pahler; Peter Olson; Aram F Hezel; James Horner; Gregory Y Lauwers; Douglas Hanahan; Ronald A DePinho
Journal:  Genes Dev       Date:  2006-11-15       Impact factor: 11.361

7.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

8.  Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

Authors:  Se-Jin Lee; Lori A Reed; Monique V Davies; Stefan Girgenrath; Mary E P Goad; Kathy N Tomkinson; Jill F Wright; Christopher Barker; Gregory Ehrmantraut; James Holmstrom; Betty Trowell; Barry Gertz; Man-Shiow Jiang; Suzanne M Sebald; Martin Matzuk; En Li; Li-Fang Liang; Edwin Quattlebaum; Ronald L Stotish; Neil M Wolfman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

9.  Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.

Authors:  F F Zhu; P B Zhang; D H Zhang; X Sui; M Yin; T T Xiang; Y Shi; M X Ding; H Deng
Journal:  Diabetologia       Date:  2011-07-14       Impact factor: 10.122

10.  Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors.

Authors:  Cécile Haumaitre; Olivia Lenoir; Raphaël Scharfmann
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.